The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Reneo Pharmaceuticals, Inc.(NASDAQ:RPHM) 
Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patie...
Website: http://reneopharma.com
Founded: 2014
CEO: Gregory J. Flesher
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Reneo Pharmaceuticals . Days Payable Outstanding ttm (DPO)
Reneo Pharmaceuticals . Op Cashflow Per Share ttm
Reneo Pharmaceuticals . Free Cashflow Per Share ttm
Reneo Pharmaceuticals . Cash Per Share ttm
Reneo Pharmaceuticals . (GAAP) P/E ratio ttm
Reneo Pharmaceuticals . P/B ratio ttm
No extra charts and metrics for this ticker.